SLA - SILK LASER AUSTRALIA LIMITED

[manoli98]

In reply to: Spicer69 on Wednesday 18/07/07 12:19am

I'm German and excuse for my english. May be it is to strong sometimes. However, it's good for the entertainment in the board IMO! I'm absolutely convinced for SLA an hold many securities many years. Hope the best for next future. http://www.sharescene.com/html/emoticons/smile.gif

[Lizard]

Herald Sun.

 

Tiny Biotech Set to De-liver

[drainer]

In reply to: Lizard on Wednesday 18/07/07 05:36am

Great article for those yet to discover SLA.

 

I am guessing it must be more than just approval as they have had many months to draft an announcement up for that.

 

Maybe a beautiful set of numbers alongside approval for a real share price kicker when the halt is lifted.

 

Good luck to all holders and those that jump on board.

 

Best long term growth story on the ASX IMHO of course.

[drainer]

In reply to: drainer on Wednesday 18/07/07 06:00am

 

ACKNOWLEDGEMENT TO THE HERALD SUN.

 

 

Tiny biotech set to de-liverArticle from: Font size: Decrease Increase Email article: Email Print article: Print John Beveridge

 

July 18, 2007 12:00am

A SMALL Melbourne biotechnology company has achieved a major breakthrough after getting pharmaceutical registration in Russia.

 

Solagran will today announce that its drug Ropren can be prescribed for liver disease in Russia.

 

That means the drug should start to sell in Russia this year, with the next development steps being to seek approval in the rest of Europe and the United States.

 

Trials have shown Ropren and its active ingredient Bioeffective R is highly effective in treating chronic liver diseases including various forms of hepatitis and cirrhosis.

 

Further trials both in Russia and Melbourne have also shown Ropren could also be effective in normalising blood lipids such as cholesterol and in treating and preventing neurodegenerative conditions such as Alzheimers and Parkinson's disease.

 

Solagran shares have been in a trading halt since Monday pending today's announcement.

 

They have traded from a low of 17 in September last year to a high of $1.55 in May this year.

 

Solagran has already announced that it is dramatically ramping up European production of Ropren to cater for the estimated 10 million people with liver disease in Russia.

 

Unlike most drugs, the active ingredient in Ropren is a natural compound known as a polyprenol that is isolated from green conifer needles.

 

It was first developed in Russia by Professor Victor Roschinback in 1986.

 

Since Solagran listed in 2003, executive chairman Dr Vagif Soultanov and a Russian project team have successfully pushed to have the drug registered in Russia.

 

That registration process was shortened significantly because clinical trials showed Ropren to be effective without any of the usual side effects of liver disease drugs.

 

The Russian Ministry of Health was also keen to introduce a locally discovered drug to combat the high number of liver disease sufferers in the country.

 

Initially supply of Solagran will be restricted by production, so most treatment courses will be prescribed in Moscow and St Petersburg.

 

Capacity expansion should see supply grow to the rest of Russia over the next few years.

 

Given Ropren has pharmaceutical approval in Russia, it may also be used when indicated to treat situations other than its primary role in restoring liver function.

 

That could include novel applications such as helping to prevent neuronal cell death in the brain following heart attack or stroke and conditions associated with drug and alcohol addiction.

 

HEARD ANYTHING?

PHONE: 9292 2756

FAX: 9292 1834

EMAIL: beveridgej@heraldsun.com.au

 

[drainer]

In reply to: drainer on Wednesday 18/07/07 06:03am

I wonder how he knows this before the ASX release expected or is he taking a stab.

 

Interesting,all though i suppose it doesnt matter if he got the good oil yesterday and they announce before the market opens this morning.

 

Will be at work unless it rains so will probably miss the action although the weather is a bit suss at the moment.

 

Good luck everyone

[manoli98]

it's great!!!!!!

[diana]

In reply to: manoli98 on Wednesday 18/07/07 06:21am

Manoli, that is the understatement of the decade. This is going to revolutionise health prospects for soooooo many people! To be part of such a great discovery and the bringing to market of such a great discovery is unbelievable!!! http://www.sharescene.com/html/emoticons/biggrin.gif

GO SLA!

R/Di

 

PS: After this, there will be a raft of other releases! http://www.sharescene.com/html/emoticons/graduated.gif

[manoli98]

In reply to: diana on Wednesday 18/07/07 06:48am

I agree with you - SLA becomes Microsoft of Australia!

[nifty49]

In reply to: diana on Wednesday 18/07/07 07:48am

Mornin' all

 

Well the ball has been bounced, let the games begin.

 

Gentlemen, start your engines!

 

Exposure in the media beforehand suggests SLA has commenced their PR campaign. A professional leak?

 

SLA to make ann before 10.00 AM today.

 

Bring it on. Good luck to all holders and well deserved.

 

Nifty http://www.sharescene.com/html/emoticons/wub.gif

[console]

In reply to: drainer on Wednesday 18/07/07 06:18am

I reckon it must have been a press release at midnight last night aimed for todays news. http://www.sharescene.com/html/emoticons/biggrin.gif